iSpecimen Inc. (NASDAQ:ISPC) Sees Large Growth in Short Interest

iSpecimen Inc. (NASDAQ:ISPC) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 75,000 shares, an increase of 82.0% from the October 31st total of 41,200 shares. Approximately 9.4% of the shares of the stock are sold short. Based on an average trading volume of 419,400 shares, the days-to-cover ratio is currently 0.2 days.

iSpecimen Stock Performance

Shares of iSpecimen stock traded up $0.07 during trading hours on Thursday, hitting $4.22. The company’s stock had a trading volume of 44,602 shares, compared to its average volume of 194,959. The company has a market cap of $4.05 million, a PE ratio of -0.22 and a beta of 1.59. The business has a 50 day moving average price of $4.63 and a two-hundred day moving average price of $1.91. iSpecimen has a 12-month low of $3.41 and a 12-month high of $12.59.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.